Study of the Effects of Probiotics Upon Infectious Episodes in Subject Aged More Than 60, During Winter.
Not Applicable
Completed
- Conditions
- Infectious Episodes (ENT, Gastro-intestinal and Pulmonary)
- Interventions
- Dietary Supplement: Lactobacillus helveticus R0052, Bifidobacterium bifidum R0071, Bifidobacterium infantis R0033Dietary Supplement: Starch of potato
- Registration Number
- NCT00796393
- Lead Sponsor
- Institut Rosell Lallemand
- Brief Summary
We put forward that probiotics have an effect on infectious episodes evolution in subjects aged 60 years or over. The main objective of this research is to observe the effect of consumption of the probiotic on the average number of days with infectious episodes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- Subjects who accept not to alter their food habits
Exclusion Criteria
- Food allergy
- Regular consumption of probiotics
- Diabetes
- Respiratory deficiency
- Cardiac deficiency
- Cancer or chronicle disease not stabilized
- Splenectomy, sickle-cell anemia
- Immuno depression or immunodeficiency acquired or congenital
- Immuno depressor or corticoid treatments
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2 Lactobacillus helveticus R0052, Bifidobacterium bifidum R0071, Bifidobacterium infantis R0033 Subject with active product, not vaccinated against influenza. 3 Starch of potato Subject with placebo, vaccinated against influenza. 4 Starch of potato Subject with placebo, not vaccinated against influenza. 1 Lactobacillus helveticus R0052, Bifidobacterium bifidum R0071, Bifidobacterium infantis R0033 Subject with active product, vaccinated against influenza
- Primary Outcome Measures
Name Time Method Number of infectious episodes During the study
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Biofortis
🇫🇷Nantes, France